Introduction
Despite the effectiveness of current antiretroviral therapies in suppressing disease progression, many HIV-positive people report using complementary and alternative medicine (CAM) to manage HIV-symptoms and side-effects of conventional HIV medication. Complementary and alternative medicine refers to a group of diverse medical and healthcare systems, therapies and products (e.g. nutritional supplements, herbal remedies, acupuncture, meditation) that are not presently considered a part of medical training or practice in countries where allopathic medicine forms the basis of the national healthcare system (Eisenberg et al., 1993 ; National Center for Complementary and Alternative Medicine [NCCAM], n.d.). Use of CAM in the general US population has steadily increased over the past 15 years (Barnes, Powell-Griner, McFann, & Nahin, 2004; Eisenberg et al., 1998 Eisenberg et al., , 1993 and rates of CAM use are exceptionally high among individuals with life-threatening illness, including HIV (Wootton & Sparber, 2001) . With little evidence supporting the safety and efficacy of CAM for HIV (Mills, Wu, & Ernst, 2005; Power, Gore-Felton, Vosvick, Israelski, & Spiegel, 2002) , research that identifies factors associated with CAM use and the implications of CAM use for HIV care is of considerable importance.
On average, published research indicates that 60% of HIV-positive individuals use CAM to treat HIV-related health concerns (e.g. Duggan, Peterson, Schutz, Khuder, & Charkraborty, 2001; Mikhail et al., 2004) . In the context of conventional HIV care, where survival depends on proper use of and adherence to highly-active antiretroviral treatment (HAART) (Lohse et al., 2007) , the potential for CAM use to interfere with the success of HAART is a pressing concern. Indeed, use of certain types of CAM may compromise the efficacy of HAART as a result of an unanticipated drug interaction or sideeffect of CAM (Ernst, 2002; Hennessy et al., 2002) . The potential for adverse outcomes may be amplified when HIV-positive patients do not disclose their CAM use to their primary HIV care providers or when patients' preferences for CAM interfere with uptake of conventional HIV treatments (Gold & Ridge, 2001; Kremer, Ironson, Schneiderman, & Hautzinger, 2006) . Prior to HAART, research investigating CAM use among HIV-positive patients focused on describing the prevalence and types of CAM used and characterizing HIV-positive CAM users on a range of demographic, biomedical and psychosocial indices. More recently, CAM research has expanded to focus on patients' reasons for using CAM and to address how CAM is incorporated into conventional HIV care.
To characterize the factors associated with CAM use and synthesize the literature on the potential impact of CAM use on HIV care, we conducted a critical review of research investigating CAM use among people living with HIV. To date, only one review on CAM use among HIV-positive individuals has been conducted (Wootton & Sparber, 2001) . Since the publication of Wootton and Sparber's review, an additional 22 studies of CAM use have been published characterizing the demographic, biomedical, psychosocial and health behavior correlates of CAM use. In addition to providing a concise synthesis of research dating back to the early stages of the HIV epidemic, important conceptual and methodological limitations in this literature are identified and implications of review findings for the provision of conventional HIV care are discussed.
Methods
Literature available in MEDLINE and PsychINFO was searched using the following keywords: HIV and complementary medicine; alternative medicine; complementary therapy; and alternative therapy. References from the studies retrieved from the computer assisted search were consulted to identify additional studies not detected in either database. Seventy-eight English language articles published in peer-reviewed journals were screened for inclusion. Studies were included if they assessed HIV-positive patients' use of CAM using qualitative or quantitative methodology and defined CAM use as a purposeful action taken to treat, cope with or alleviate HIV symptoms or side-effects of conventional HIV treatment. Studies exploring CAM use not specifically directed at treatment of HIV and studies examining the efficacy of CAM were excluded. According to these criteria, 40 studies were included.
Review findings
Review findings are organized as follows. First, we describe the demographic, biomedical and psychosocial correlates of CAM use among HIV-positive individuals. Second, a synthesis of research describing HIV-positive patients' reasons for using CAM is provided. Third, we review literature investigating whether HIV-positive patients' use of CAM interferes with conventional HIV care. For cross-reference, Table 1 summarizes the sample size, recruitment source, assessment methodology, rate of CAM use, types of CAM used and primary study findings for each study.
Demographic correlates of CAM use
Our review indicates that CAM use among HIVpositive people is disproportionately higher among Caucasians as compared to minority respondents (Bates, Kissinger, & Bessinger, 1996; Gore-Felton et al., 2003; Hsiao et al., 2003; Risa et al., 2002; Smith, Boyd, & Kirking, 1999; Suarez & Reese, 1997 Wutoh et al., 2001) , men who have sex with men as compared to respondents of other sexual orientations (Bica et al., 2003; Hsiao et al., 2003; London, Foote-Ardah, Fleishman, & Shapiro, 2003; Smith et al., 1999; Suarez & Reese, 2000) , individuals with more education (Bates et al., 1996; Bica et al., 2003; Chang, van Servellen, & Lombardi, 2003; Colebunders, Dreezen, Florence, Pelgrom, & Schrooten, 2003; de Visser & Grierson, 2002; Fairfield, Eisenberg, Davis, Libman, & Phillips, 1998; Hsiao et al., 2003; Mikhail et al., 2004; Ostrow et al., 1997; Smith et al., 1999; Tsao, Dobalian, Myers, & Zeltzer, 2005) and those who have higher incomes (Bica et al., 2003; Duggan et al., 2001; London et al., 2003; Ostrow et al., 1997) . Research is inconclusive with regard to the role of gender and age in predicting CAM use. This pattern of findings suggests that CAM use (and presumably, access to CAM) is more likely among individuals who have greater education and financial resources.
Health-related correlates of CAM use
Describing the relationship between CAM use and health status is an important step toward understanding the role of illness experiences in the decision to use CAM among HIV-positive people. Research examining the relationship between CAM use and health status indicates that HIV-positive individuals who have been diagnosed with AIDS (Jernewall, Zea, Reisen, & Poppen, 2005) , experienced symptoms of HIV (Knippels & Weiss, 2000; Mikhail et al., 2004; Suarez, Raffaelli, & O'Leary, 1996) or have longer disease duration (Anderson, O'Connor, MacGregor, & Schwartz, 1993; Colebunders et al., 2003; Mikhail et al., 2004; Woolridge et al., 2005) are more likely to use CAM than healthier individuals or those with shorter disease duration. In addition, several studies indicate that CAM use is associated with greater HIV-symptom severity (Chang et al., 2003; Ostrow et al., 1997) and a higher degree of disability (Burg, Uphold, In analyses that combined both cohorts: use of homeopathy associated with longer time since HIV diagnosis and lower CD4' count and use of herbal products associated with longer time since diagnosis and more advanced disease stage. de Visser, R. (2002) Community sample: n 0924 Australians (91% male) Quantitative: Self-administered survey 55 Vitamin, mineral, nutrient supplements (46) Massage therapy (28) Meditation (20) Herbal medicine (19) Acupuncture (8) CAM use more common among females, those who have more education, a major co-morbid health condition, read HIV/AIDS media and spend more time with other HIV-positive individuals CAM use associated with more favorable attitudes toward CAM and less favorable attitudes toward HAART (89) Activities (64) Naturopathic products (39) Practitioners (38) Use of any CAM is more common among female respondents Use of CAM activities is more common among respondents who are female, unemployed, receiving disability benefits and report more overall drug use Use of CAM providers is more common among respondents with more education and higher viral load (4) Homeopathy (3) Ingested CAM use (22%) more common among participants who are white, male and more educated Use of CAM as a substitute for traditional treatment (2.5%) associated with a greater desire for involvement in medical decision-making and belief that antiretroviral medication is ''definitely not worth taking'' Food supplements (63) Homeopathy (21) Herbal medicine (17) Yoga, meditation, imagery, massage (16) Acupuncture (6) CAM use associated with disease stage (symptomatic patients use more CAM), use of active coping, use of emotion-focused coping and lower levels of self-reported pain (MOS-pain) CAM use prior to HAART use: Megavitamins (14) Relaxation (10) Spiritual healing (8) CAM use'HAART use:
Megavitamins (9) Massage (7) Herbal remedies (5) CAM use associated with higher levels of distress, problemfocused coping, lower belief in efficacy of HAART and being Caucasian CAM users who started using CAM after initiation of HIV meds were more likely to be African-American and have higher income compared with prior users Singh, N. (5) Vitamin, herbal product and recreational drug use more common among Caucasians Herbal product use more common among those with more than high-school education and those receiving psychological care 
Psychosocial correlates of CAM use
Research seeking to determine whether HIV-positive CAM users differ from non-users with respect to depressive symptomology and coping approaches has yielded mixed findings. With respect to psychological adjustment, only one study found higher levels of distress among CAM users as compared to non-users (Risa et al., 2002) . There is more evidence to suggest that CAM use is associated with fewer depressive symptoms (Gore-Felton et al., 2003; Suarez & Reese, 2000) and better mental health (Sugimoto et al., 2005) . Several studies suggest that CAM use is associated with the use of more adaptive approaches to coping with HIV-related stressors, including problem-focused coping, positive reinterpretation and growth, seeking social support, planning and turning to religion (Knippels & Weiss, 2000; Suarez & Reese, 1997 . In addition, HIV-positive CAM users are more likely than non-users to appraise HIV as a controllable stressor (Suarez & Reese, 1997 . Finally, a number of studies report null findings for coping and depression outcomes (Bica et al., 2003; Burg et al., 2005; Fairfield et al., 1998; Ostrow et al., 1997; Singh et al., 1996; Suarez et al., 1996) . Needed now is research that examines the extent to which CAM use is linked to HIV-specific coping behaviors.
Reasons for CAM use among HIV-positive people
Understanding why some HIV-positive people choose to use CAM is of importance because of the potential for CAM use to interfere with the success of HAART. Sixteen of the reviewed studies assessed HIV-positive patients' reasons for using CAM. In Table 2 , we describe five themes that emerged from our synthesis of these studies. In brief, HIV-positive patients report that they use CAM primarily for practical reasons: to alleviate HIV-symptoms and HAART side-effects and to improve quality of life. For some HIV-positive people, CAM offers a means of addressing their concerns with conventional treatment and engaging in healthcare practices that align with their health beliefs. To clarify why some HIVpositive patients use CAM whereas others do not, quantitative research into the relationship between CAM use and patients' reasons for CAM use is needed. General physical and psychological health maintenance and benefits CAM is used as a general method of promoting health or to improve or maintain quality of life Bates et al., 1996; Carwein & Sabo, 1997; Furler et al., 2003; Gillett et al., 2001; Langewitz et al., 1994; Pawluch et al., 2000 HIV-specific benefits CAM used to treat nutritional deficiencies, fatigue and nausea, and to alleviate pain related to peripheral neuropathy progression CAM used to augment the effects of conventional HIV treatments Agnoletto et al., 2003; Anderson et al., 1993; Fairfield et al., 1998; Langewitz et al., 1994; Pawluch et al., 2000; Sparber et al., 2000; Tsao et al., 2005; Woolridge et al., 2005 CAM use to alleviate medication side-effects CAM used concurrently with conventional HIV medications to prevent or ameliorate side-effects (e.g. gastrointestinal and dermatological problems, fatigue, neuropathy and lipodystrophy) Agnoletto et al., 2003; Bates et al., 1996; Foote-Ardah, 2003; Pawluch et al., 2000; Standish et al., 2001 Concerns with conventional HIV treatment CAM is viewed as safe alternative to conventional HIV medications CAM used as a way of responding to or counteracting the potential longterm adverse effects of HAART CAM is used because it is more congruent with patients' culture or health beliefs -Ardah, 2003; Gillett et al., 2001; Pawluch et al., 2000; Standish et al., 2001; Suarez et al., 1996 Desire for greater involvement in healthcare CAM use provides a way of being more actively involved in one's healthcare and treatment decisions Foote-Ardah, 2003; Gillett et al., 2001; Sparber et al., 2000 AIDS Care 1013
Foote
Implications of CAM use for conventional HIV care While many HIV-positive individuals use CAM to treat HIV symptoms and HAART side-effects, the extent to which these self-directed healthcare practices impact the success of conventional HIV care is largely unknown. In the following sections, research evaluating the relationship between CAM use and adherence to conventional treatment, attitudes toward conventional medicine and disclosure of CAM use are reviewed.
HAART adherence and CAM use
Seven studies have evaluated the association between CAM use and adherence. Two studies identified an association between CAM use and treatment nonadherence. Jernewall and colleagues (2005) found that users of ''Latino CAM'' (i.e. traditional healing practices in Latino culture such as Curanderismo, Espiritismo and Santeria) were less likely to attend medical appointments and had lower rates of HAART adherence for past three days. In addition, users of plant-based remedies had lower rates of adherence to HAART (Jernewall et al., 2005) . More recently, HIV-positive women who reported using orally-administered CAM to treat their HIV (primarily vitamins and immunity boosters) were more likely to report missing at least one dose of their prescribed HIV medications in the past 30 days (Owen- Smith, Diclemente, & Wingood, 2007) . The remaining studies found no differences in HAART adherence between CAM users and non-users (Bica et al., 2003; de Visser & Grierson, 2002; Knippels & Weiss, 2000; Risa et al., 2002; Wutoh et al., 2001) .
Attitudes toward conventional medicine and the decision to use CAM Early in the HIV epidemic, research suggested that HIV-positive CAM users were more likely than nonusers to perceive conventional HIV medications as ineffective (Langewitz, Ruttimann, Laifer, Maurer, & Kiss, 1994) . Although HAART provides substantial clinical benefits, concerns about side-effects and longterm health consequences of HAART contribute to less favorable attitudes toward conventional medicine and poorer medication adherence (Johnson et al., 2005; Remien et al., 2003) . Negative attitudes toward HAART may also influence the decision to use CAM. For example, CAM use was strongly associated with more favorable attitudes toward CAM (e.g. the perception that CAM delays illness progression and boosts immune functioning) and less favorable attitudes toward HAART (de Visser & Grierson, 2002) . In another study, patients who believe that conventional HIV medications are ''definitely not worth taking'' were eight times more likely to use CAM as a substitute for conventional treatment as compared to those who believe that conventional treatments are ''worth taking'' (Hsiao et al., 2003) . Given that data collection for these studies was completed prior to widespread use of HAART, findings may not be representative of patients' beliefs about HAART today. Further research exploring the interplay between HAART beliefs, CAM use and adherence is needed.
Non-disclosure of CAM use to conventional care providers
Patient-provider communication about CAM use would presumably reduce the risk for adverse health outcomes that may result from drug interactions or misuse of conventional medication. Complementary and alternative medicine use disclosure rates vary substantially across studies, with 38Á90% of patients reporting that their physician is aware of their CAM use (Chang et al., 2003; Duggan et al., 2001; Fairfield et al., 1998; Furler, Einarson, Walmsley, Millson, & Bendayan, 2003; Hsiao et al., 2003; Risa et al., 2002; Sparber et al., 2000; Standish et al., 2001) . Although no studies have investigated the link between CAM use disclosure and HIV-related health outcomes, research strongly suggests a need for routine assessment and discussion of CAM use among HIVpositive patients.
Discussion
While the efficacy of many CAM approaches has yet to be demonstrated, this review confirms that CAM use is highly prevalent among people living with HIV.
Review findings indicate that CAM use is more common among HIV-positive individuals with greater education and financial resources. Complementary and alternative medicine users are more likely to have experienced symptoms of HIV disease progression and to have longer disease duration. Findings with respect to the association of CAM use with depressive symptoms and the use of active coping strategies are mixed. The most commonly cited reason for CAM use has to do with the management of HIV-related symptoms and HAART side-effects. In addition, for some HIV-positive patients, the principles of CAM align with their health beliefs and CAM use provides an increased sense of control and participation in the management of their illness. By identifying underlying motives for CAM use, our review provides promising directions for quantitative studies seeking to clarify critical factors involved in CAM-related treatment decisions among HIV-positive people. An overarching conclusion from this review is the need for research exploring the intersection between CAM use and conventional treatment for HIV. Two primary concerns have received attention: (1) the potential for CAM use to interfere with use of and adherence to conventional HIV medications and (2) non-disclosure of CAM use to medical care providers. While there was only mixed support for an association between CAM use and HAART adherence, patients' beliefs about HAART may influence whether CAM is used as an adjunct or alternative to conventional medications. Further investigation of patient-provider interactions regarding CAM use is needed to clarify whether non-disclosure of CAM use contributes to adverse health outcomes.
Limitations of the reviewed literature
A number of methodological and conceptual limitations in the reviewed literature merit consideration. Complementary and alternative medicine use was usually treated as a dichotomous outcome variable in statistical models that compare respondents who have used any CAM since their HIV diagnosis with those who have not. This approach obscures the heterogeneity of healthcare practices included under the rubric of CAM and diminishes the complexity and meaning of these health behaviors. In addition, nearly all of the reviewed studies include at least one currently accepted medical intervention (e.g. vitamins) (Drain, Kupka, Mugusi, & Fawzi, 2007) in their definition of ''CAM use'', which may produce inflated estimates of CAM use and spurious associations. For example, rates of CAM use were significantly higher when either vitamins or exercise were considered CAM as compared to rates of CAM use with these activities excluded (e.g. Furler et al., 2003; Suarez & Reese, 2000) . The list of health practices considered CAM evolves as evidence of safety and efficacy accumulates. Thus, as recommended by the National Center for Complementary and Alternative Medicine (NCCAM, n.d.), future research should employ a standardized categorical framework of CAM therapies that is consistent with contemporary research.
Reviewed studies rely solely upon cross-sectional research designs. The absence of more sophisticated statistical modeling that establishes causal direction and psychological mediators is not surprising given the absence of theory-based conceptual frameworks in this literature. Indeed, with few exceptions (Hsiao et al., 2003; Smith et al., 1999; Tsao et al., 2005) , reviewed studies did not employ health behavior theory in the selection of explanatory constructs or interpretation of results. As a result, the reviewed studies examine a narrow range of factors and yield an incomplete understanding of CAM use among HIV-positive individuals.
Qualitative research suggests that patients' perceptions of HIV and HAART may influence CAM decisions. Patients' perceptions of their illness and its treatment have been shown to influence psychological adjustment, coping and treatment adherence (Horne, 2003; Horne et al., 2004; Leventhal, Brissette, & Leventhal, 2003) , but have not been examined in quantitative investigations of CAM use among HIVpositive people. Theory-driven research investigating patients' beliefs about HIV and HAART may help to clarify the relationship between CAM use and HAART adherence and identify CAM users vulnerable to adherence problems.
Implications for HIV care providers
Review findings point to several important implications for HIV care providers. First, disclosure of CAM use to HIV care providers is clearly the first step toward ensuring patients' safety. Providers are encouraged to regularly and systematically assess their patients' use of CAM. At a minimum, providers should document the types, sources and expected benefits of CAM, as well as the patients' experiences with each type of CAM, including the duration and frequency of use and perceived effects of CAM. Second, providers who understand their patients' reasons for using CAM may be in a better position to address the potential risks associated with CAM use (e.g. poor adherence to HAART). For example, CAM use and non-disclosure of CAM use may stem from mistrust of the healthcare system and, by proxy, the providers in it. Alternatively, CAM use may signal a desire for increased involvement in one's healthcare, misperceptions concerning conventional treatment or idiosyncratic health beliefs. In sum, assessment of CAM use gives clinicians a chance to provide accurate and unbiased information on CAM and to work collaboratively with CAM users to develop treatment plans that optimize adherence to prescribed treatments, satisfaction with care and health outcomes.
Conclusion
The cumulative research on CAM use among HIVpositive people focuses on characterizing CAM users, describing reasons for CAM use and exploring the implications of CAM use for conventional HIV care. To advance this important area of study, AIDS Care 1015 theory-based research is needed to clarify how patients' beliefs about HIV and HAART guide their decisions to use CAM. Using theory to conceptualize how patients' beliefs influence treatment decisions will help to inform the development of interventions designed to improve patient-provider communication regarding CAM and reduce the potential for CAM use to interfere with proper use of conventional treatments. Many HIV-positive patients view CAM as an important part of their care. As such, providers should strive to incorporate routine assessment of CAM use as a means of informing treatment planning and maximizing long-term health outcomes for their HIV-positive patients.
